Old Web
English
Sign In
Acemap
>
Paper
>
進行胃癌のIO(Imuno-Oncology)治療薬選択;MSI/MMR firstか,標準治療後の全患者対象か?
進行胃癌のIO(Imuno-Oncology)治療薬選択;MSI/MMR firstか,標準治療後の全患者対象か?
2019
luzehao
haneda makoto akira
amano hiroyuki
miura yuuko
zhongyuguizi
ooyama kou
hosoda kenzi
suzuki youzi
kozima yuuitirou
yugongjianer
hirotu yousuke
motizuki hitosi
oyama tosio
omata masao
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]